Literature DB >> 26651362

IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies.

Lasse Saaby1, Hans Christian Cederberg Helms2, Birger Brodin2.   

Abstract

The P-glycoprotein (P-gp) efflux pump has been shown to affect drug distribution and absorption in various organs and to cause drug resistance in cancer therapy. The aim of this work was to develop a cell line to serve as a screening system for potential substrates of P-gp. This requires a cell line with high paracellular tightness, low expression of nonhuman ABC transporters, and high expression of functional human P-gp (ABCB1). The porcine intestinal epithelial cell line, IPEC-J2, was selected as a transfection host, due to its ability to form extremely high-resistance monolayers (>10,000 Ω·cm(2)) and its low endogenous expression of ABC-type efflux transporters. The IPEC-J2 cells were transfected with a plasmid that contained the sequence of the human MDR1 gene, which encodes P-gp, followed by a selection of successfully transfected cells with geneticin and puromycin. The resulting cell line, IPEC-J2 MDR1, retained its high transepithelilal resistance (>15,000 Ω·cm(2)), which translated into low permeability of the small hydrophilic tracer, mannitol (P < 10(-7) cm·s(-1)). The lipophilic compound, diazepam, displayed high permeability resulting in a dynamic range of 1500 (PDiazepam/Pmannitol) to separate high and low permeability compounds. Human P-gp was expressed predominantly in the apical membrane, as demonstrated by immunocytochemistry, Western blots, and a high efflux ratios (Pbasolateral-apical/Papical-basolateral) of known P-gp substrates. P-gp was demonstrated to be responsible for the efflux transport by substrate profiling, combined with application of P-gp and BCRP inhibitors. Furthermore, the compounds atenolol, citalopram, and mitoxantrone were identified as P-gp substrates. Functional P-gp expression was shown to be stable through at least 10 cell passages. In conclusion, the IPEC-J2 MDR1 cell line displays high paracellular tightness combined with high expression of human P-gp and low expression of porcine ABC transporters, and it may serve as a useful tool in drug development studies.

Entities:  

Keywords:  CNS drug screening; P-gp mediated drug efflux; P-gp substrates; drug delivery; drug disposition; drug screening; drug transporters; in vitro model; intestinal cell model; multidrug resistance

Mesh:

Substances:

Year:  2016        PMID: 26651362     DOI: 10.1021/acs.molpharmaceut.5b00874

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  The blood-brain barrier studied in vitro across species.

Authors:  Maj Schneider Thomsen; Nanna Humle; Eva Hede; Torben Moos; Annette Burkhart; Louiza Bohn Thomsen
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

Review 2.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

3.  Large Animal Models: The Key to Translational Discovery in Digestive Disease Research.

Authors:  Amanda Ziegler; Liara Gonzalez; Anthony Blikslager
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-11

4.  Revisiting atenolol as a low passive permeability marker.

Authors:  Xiaomei Chen; Tim Slättengren; Elizabeth C M de Lange; David E Smith; Margareta Hammarlund-Udenaes
Journal:  Fluids Barriers CNS       Date:  2017-10-31

Review 5.  Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches.

Authors:  David Dahlgren; Hans Lennernäs
Journal:  Pharmaceutics       Date:  2019-08-13       Impact factor: 6.321

Review 6.  Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery.

Authors:  Rong Lu; Yun Zhou; Jinqian Ma; Yuchen Wang; Xiaoqing Miao
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

7.  Structural features and antioxidant activities of polysaccharides from different parts of Codonopsis pilosula var. modesta (Nannf.) L. T. Shen.

Authors:  Li-Xia Li; Meng-Si Chen; Zi-Yu Zhang; Berit Smestad Paulsen; Frode Rise; Chao Huang; Bin Feng; Xing-Fu Chen; Ren-Yong Jia; Chun-Bang Ding; Shi-Ling Feng; Yang-Ping Li; Yu-Long Chen; Zhen Huang; Xing-Hong Zhao; Zhong-Qiong Yin; Yuan-Feng Zou
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

8.  A Novel Derivative of Thioridazine Shows Low Toxicity and Efficient Activity against Gram-Positive Pathogens.

Authors:  Nadia S Jørgensen; Lasse Saaby; Anne M Andersson; Sofie Kromann; Ehsan Sheikhsamani; Anders Permin; Troels Ronco; Søren W Svenningsen; Jørn B Christensen; Rikke H Olsen
Journal:  Antibiotics (Basel)       Date:  2020-06-15

Review 9.  Mycotoxins: Biotransformation and Bioavailability Assessment Using Caco-2 Cell Monolayer.

Authors:  Van Nguyen Tran; Jitka Viktorová; Tomáš Ruml
Journal:  Toxins (Basel)       Date:  2020-09-30       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.